These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 11191270)

  • 1. Validation of markers for their relevance to health and disease.
    Antoine JM; Diplock AT
    Free Radic Res; 2000 Nov; 33 Suppl():S117-20. PubMed ID: 11191270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human studies to substantiate health effects of antioxidants. What is needed?
    van't Veer PV; Kok FJ
    Free Radic Res; 2000 Nov; 33 Suppl():S109-115. PubMed ID: 11191269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemometrics in metabolomics--a review in human disease diagnosis.
    Madsen R; Lundstedt T; Trygg J
    Anal Chim Acta; 2010 Feb; 659(1-2):23-33. PubMed ID: 20103103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of FibroTest inter-laboratory variations requires standardization on analytical systems and should not be mixed with underpowered histological validation.
    Munteanu M; Imbert-Bismut F; Housset C; Messous D; Fellahi S; Poynard T
    Clin Chim Acta; 2010 Feb; 411(3-4):292-3. PubMed ID: 19931523
    [No Abstract]   [Full Text] [Related]  

  • 5. Considerations on development, validation, application, and quality control of immuno(metric) biomarker assays in clinical cancer research: an EORTC-NCI working group report.
    Sweep FC; Fritsche HA; Gion M; Klee GG; Schmitt M;
    Int J Oncol; 2003 Dec; 23(6):1715-26. PubMed ID: 14612946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic strategies for biomarker identification: progress and challenges.
    Fung ET; Wright GL; Dalmasso EA
    Curr Opin Mol Ther; 2000 Dec; 2(6):643-50. PubMed ID: 11249741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated image analysis of cytokinesis-blocked micronuclei: an adapted protocol and a validated scoring procedure for biomonitoring.
    Decordier I; Papine A; Plas G; Roesems S; Vande Loock K; Moreno-Palomo J; Cemeli E; Anderson D; Fucic A; Marcos R; Soussaline F; Kirsch-Volders M
    Mutagenesis; 2009 Jan; 24(1):85-93. PubMed ID: 18854579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative and non-oxidative DNA damage and cardiovascular disease.
    Malik Q; Herbert KE
    Free Radic Res; 2012 Apr; 46(4):554-64. PubMed ID: 22303808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic biomarkers for cancer assessment: implementation challenges for laboratory practice.
    Pritzker KP; Azad A
    Clin Biochem; 2004 Jul; 37(7):642-6. PubMed ID: 15234245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human biomonitoring: state of the art.
    Angerer J; Ewers U; Wilhelm M
    Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sensitivity and specificity of markers for event times.
    Cai T; Pepe MS; Zheng Y; Lumley T; Jenny NS
    Biostatistics; 2006 Apr; 7(2):182-97. PubMed ID: 16079162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multidimensional assessment of coping: validation of the Brief COPE among French population].
    Muller L; Spitz E
    Encephale; 2003; 29(6):507-18. PubMed ID: 15029085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction: markers of oxidative damage and antioxidant modulation.
    Diplock AT
    Free Radic Res; 2000 Nov; 33 Suppl():S21-6. PubMed ID: 11191271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An approach to the validation of biomarkers of harm for use in a tobacco context.
    Gregg EO; Fisher AL; Lowe F; McEwan M; Massey ED
    Regul Toxicol Pharmacol; 2006 Apr; 44(3):262-7. PubMed ID: 16442193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a new method to measure hydrogen peroxide in exhaled breath condensate.
    Gerritsen WB; Zanen P; Bauwens AA; van den Bosch JM; Haas FJ
    Respir Med; 2005 Sep; 99(9):1132-7. PubMed ID: 16085214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of oxidative damage and antioxidant protection: assessment of LDL oxidation.
    Salonen JT
    Free Radic Res; 2000 Nov; 33 Suppl():S41-6. PubMed ID: 11191274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases.
    Aviram M
    Free Radic Res; 2000 Nov; 33 Suppl():S85-97. PubMed ID: 11191279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cyclic GMP as a biomarker for cardiovascular disease and cancer].
    Ulvestad L; Sager G
    Tidsskr Nor Laegeforen; 2005 Jan; 125(1):27-8. PubMed ID: 15643459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of commercial DNA tests for quantitative beef quality traits.
    Van Eenennaam AL; Li J; Thallman RM; Quaas RL; Dikeman ME; Gill CA; Franke DE; Thomas MG
    J Anim Sci; 2007 Apr; 85(4):891-900. PubMed ID: 17178813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.